Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study

SIMPLE SUMMARY: The early detection of primary resistance to anti-PD1 immunotherapies remains a major challenge in the management of metastatic melanoma. In a previous study, we suggested that early monitoring of circulating tumor DNA (ctDNA) using well-defined evaluation criteria allows the identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbreteau, Guillaume, Vallée, Audrey, Knol, Anne-Chantal, Théoleyre, Sandrine, Quéreux, Gaëlle, Varey, Emilie, Khammari, Amir, Dréno, Brigitte, Denis, Marc G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069589/
https://www.ncbi.nlm.nih.gov/pubmed/33920470
http://dx.doi.org/10.3390/cancers13081826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069589/
https://www.ncbi.nlm.nih.gov/pubmed/33920470
http://dx.doi.org/10.3390/cancers13081826

Ejemplares similares